BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 27, 2011
View Archived Issues
Avila Therapeutics describes new BTK inhibitor
Read More
BF-200 ALA shows efficacy in treating actinic keratosis in advanced studies
Read More
Influenza HA1-flagellin fusion vaccines well tolerated in healthy volunteers
Read More
GlaxoSmithKline presents novel TRPV4 channel antagonists
Read More
New agents for HCV infection synthesized by Vertex Pharmaceuticals
Read More
Orphan drug status for Atox Bio's AB-103
Read More
FDA clears kit to aid in determining AML prognosis
Read More
Conatus Pharmaceuticals terminates phase II CTS-1027 study
Read More
Celiac disease candidate therapy completes proof-of-principle phase II study
Read More
Phase II trial evaluates fingolimod in Japanese patients with MS
Read More
NIH grant awarded for AEOL-10150 as medical countermeasure against nerve agents
Read More
High Point Pharmaceuticals claims new beta-secretase inhibitors
Read More
Studies assess [11C]-choline PET/CT as prostate cancer staging tool
Read More
Poxel reports encouraging phase II data on imeglimin
Read More
Immunovaccine clear to start phase I/II DPX-Survivac trial in Canada
Read More
New conjugated neuroactive steroids disclosed in U.S.
Read More
Novel soluble guanylate cyclase activators described by Merck & Co.
Read More
Ajinomoto prepares novel calcium-sensing CaS receptor agonists
Read More
Bristol-Myers Squibb and Gilead Sciences enter licensing agreement for antiretroviral regimen
Read More
AtheroNova completes pre-IND meeting with FDA on atherosclerosis therapy
Read More
Solasia Pharma begins study of darinaparsin injection in Japan
Read More
S*BIO plans phase III program for pacritinib
Read More
Phase III study finds Latuda noninferior to Seroquel XR
Read More
Bionovo opens enrollment for pivotal trial of Menerba
Read More
FDA extends PDUFA action date for dapagliflozin NDA
Read More
